Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
US Army
Boehringer Ingelheim
Express Scripts
UBS
Colorcon
US Department of Justice
Federal Trade Commission
Chinese Patent Office
Medtronic

Generated: August 18, 2017

DrugPatentWatch Database Preview

Carbidopa - Generic Drug Details

« Back to Dashboard

What are the generic sources for carbidopa and what is the scope of carbidopa patent protection?

Carbidopa
is the generic ingredient in sixteen branded drugs marketed by Edenbridge Pharms, Aton, Amerigen Pharms Ltd, Alvogen Malta, Wockhardt Ltd, Sun Pharma Global, Orion Pharma, Mayne Pharma, Impax Labs Inc, Apotex, Apotex Inc, Idt Australia Ltd, Impax Labs, Accord Hlthcare, Mylan, Sun Pharm Inds, Ranbaxy, Abbvie Inc, Merck Sharp Dohme, Actavis Elizabeth, Kv Pharm, SCS, Watson Labs, and Ucb Inc, and is included in thirty-seven NDAs. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carbidopa. Eight suppliers are listed for this compound.

Summary for Generic Name: carbidopa

Tradenames:16
Patents:10
Applicants:24
NDAs:37
Drug Master File Entries: see list18
Suppliers / Packagers: see list8
Bulk Api Vendors: see list46
Clinical Trials: see list153
Patent Applications: see list4,929
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:carbidopa at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc
RYTARY
carbidopa; levodopa
CAPSULE, EXTENDED RELEASE;ORAL203312-001Jan 7, 2015RXYesNo► Subscribe► SubscribeY ► Subscribe
Impax Labs Inc
RYTARY
carbidopa; levodopa
CAPSULE, EXTENDED RELEASE;ORAL203312-002Jan 7, 2015RXYesNo► Subscribe► Subscribe► Subscribe
Mylan
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET;ORAL090324-001Sep 28, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Aton
LODOSYN
carbidopa
TABLET;ORAL017830-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Watson Labs
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET;ORAL073382-001Sep 28, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: carbidopa

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aton
LODOSYN
carbidopa
TABLET;ORAL017830-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
LODOSYN
carbidopa
TABLET;ORAL017830-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
LODOSYN
carbidopa
TABLET;ORAL017830-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Baxter
Colorcon
Fuji
US Army
Federal Trade Commission
Cantor Fitzgerald
Cipla
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot